{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-04T03:07:59.311878+00:00","company":{"ticker":"HCA","cik":860730,"company_name":"HCA Healthcare, Inc."},"pagination":{"limit":100,"returned":7,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"f1e7d4d8cbaf3361875b533232ca7ea7426a903d","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2026-04-30T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Indentures","agreement_type":"notes_offering","counterparty":"CSC Delaware Trust Company and Deutsche Bank Trust Company Americas","effective_date":"2026-04-30","item_codes_triggered":["1.01"],"value_text":"$3,000,000,000"},"claim":"HCA Healthcare, Inc. entered into Indentures with CSC Delaware Trust Company and Deutsche Bank Trust Company Americas valued at $3,000,000,000 (effective 2026-04-30).","evidence_excerpt":"On April 30, 2026, the Notes were issued pursuant to an indenture dated as of August 1, 2011 (the “Base Indenture”), among the Issuer, the Parent Guarantor, CSC Delaware Trust Company (formerly known as Delaware Trust Company) (as successor to Law Debenture Trust Company of New York), as trustee (the “Trustee”), and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (the “Paying Agent”), as amended and supplemented by, (i) with respect to the 2031 Notes, the Supplemental Indenture No. 54, dated as of April 30, 2026, among the Issuer, the Parent Guarantor, the Trustee and the Paying Agent (together with the Base Indenture, the “2031 Notes Indenture”); (ii) with respect to the 2033 Notes, the Supplemental Indenture No. 55, dated as of April 30, 2026, among the Issuer, the Parent Guarantor, the Trustee and the Paying Agent (together with the Base Indenture, the “2033 Notes Indenture”); and (iii) with respect to the 2036 Notes, the Supplemental Indenture No","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-197278","anchor_url":"https://secwatch.observer/filing/0001193125-26-197278#claim-f1e7d4d8cbaf3361875b533232ca7ea7426a903d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197278/0001193125-26-197278-index.htm"},{"fact_type":"earnings_release","fact_key":"1abe25919c5784b943a66566ffabbbdc5b8d2904","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2026-04-24T23:59:59+00:00","payload":{"eps_text":"$7.15 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$1.620 billion","period_text":"first quarter ended March 31, 2026","report_date":"2026-04-24","result_type":"reported_results","revenue_text":"$19.109 billion"},"claim":"HCA Healthcare, Inc. reported first quarter ended March 31, 2026 results: revenue $19.109 billion, net income $1.620 billion, EPS $7.15 per diluted share.","evidence_excerpt":"the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): • Revenues increased 4.3 percent to $19.109 billion • Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion • Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001193125-26-174933","anchor_url":"https://secwatch.observer/filing/0001193125-26-174933#claim-1abe25919c5784b943a66566ffabbbdc5b8d2904","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526174933/0001193125-26-174933-index.htm"},{"fact_type":"debt_financing","fact_key":"aca2f5779e254a0e5436cb31ef3c8df668fe90a8","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2025-10-31T23:59:59+00:00","payload":{"counterparty":"Public offering","effective_date":"2025-10-31","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"4.300%, 4.600%, 4.900%, 5.700%","item_codes_triggered":["2.03"],"maturity_text":"2030 Notes mature November 15, 2030; 2032 Notes mature November 15, 2032; 2035 Notes mature November 15, 2035; 2055 Notes mature November 15, 2055","principal_text":"$3,250,000,000 aggregate principal amount"},"claim":"HCA Healthcare, Inc. incurred senior notes of $3,250,000,000 aggregate principal amount with Public offering at 4.300%, 4.600%, 4.900%, 5.700% maturing 2030 Notes mature November 15, 2030; 2032 Notes mature November 15, 2032; 2035 Notes mature November 15, 2035; 2055 Notes mature November 15, 2055.","evidence_excerpt":"any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. Issuance of $3,250,000,000 aggregate principal amount of senior notes Overview On October 31, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001193125-25-260809","anchor_url":"https://secwatch.observer/filing/0001193125-25-260809#claim-aca2f5779e254a0e5436cb31ef3c8df668fe90a8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525260809/0001193125-25-260809-index.htm"},{"fact_type":"executive_change","fact_key":"144dacab96","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2025-02-24T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Meg G. Crofton retired as Director at HCA Healthcare, Inc..","evidence_excerpt":"Retirement of Meg G. Crofton from the","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-25-033430","anchor_url":"https://secwatch.observer/filing/0001193125-25-033430#claim-144dacab96","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525033430/0001193125-25-033430-index.htm"},{"fact_type":"executive_change","fact_key":"2df5e4c8e7","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2024-04-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-01","interim":false,"role":"Senior Vice President and Controller","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Christopher F. Wyatt was appointed as Senior Vice President and Controller at HCA Healthcare, Inc..","evidence_excerpt":"In conjunction with Mr. Rutherford’s retirement, Christopher F. Wyatt, age 47, will succeed Mr. Rutherford as principal accounting officer, effective May 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-125204","anchor_url":"https://secwatch.observer/filing/0001193125-24-125204#claim-2df5e4c8e7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524125204/0001193125-24-125204-index.htm"},{"fact_type":"executive_change","fact_key":"0f7c3020de","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2024-04-30T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2024-05-01","interim":false,"role":"Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer","role_category":"cfo","successor_name":"Christopher F. Wyatt","successor_named":true},"claim":"William B. Rutherford departed as Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer at HCA Healthcare, Inc..","evidence_excerpt":"As previously announced, William B. Rutherford, HCA Healthcare, Inc.’s (the “Company’s”) Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer notified the Company of his intent to retire, effective May 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-125204","anchor_url":"https://secwatch.observer/filing/0001193125-24-125204#claim-0f7c3020de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524125204/0001193125-24-125204-index.htm"},{"fact_type":"earnings_release","fact_key":"85f90cead3c7967d1f294ae3a8fed2402bf8e463","cik":860730,"ticker":"HCA","company_name":"HCA Healthcare, Inc.","filed_at":"2024-04-26T23:59:59+00:00","payload":{"eps_text":"$5.93 per diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$1.591 billion","period_text":"the first quarter ended March 31, 2024","report_date":"2024-04-26","result_type":"reported_results","revenue_text":"$17.339 billion"},"claim":"HCA Healthcare, Inc. reported the first quarter ended March 31, 2024 results: revenue $17.339 billion, net income $1.591 billion, EPS $5.93 per diluted share. Guidance reaffirmed.","evidence_excerpt":"HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): ● Revenues totaled $17.339 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-115857","anchor_url":"https://secwatch.observer/filing/0001193125-24-115857#claim-85f90cead3c7967d1f294ae3a8fed2402bf8e463","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/0001193125-24-115857-index.htm"}]}